Dong-A Pharmaceutical Executive and Leadership Team

Sung Park, the Group Chief Financial Officer at Dong-A Pharmaceutical, directs the financial strategy and fiscal operations across the entire organization. Overseeing all financial planning, budgeting, and reporting functions, Sung Park ensures robust financial health and compliance. This leadership role involves managing investment portfolios, optimizing capital allocation, and driving profitability through strategic financial management. By analyzing market trends and economic conditions, Sung Park guides the company's financial direction to support sustainable growth and shareholder value. The Group Chief Financial Officer's oversight extends to risk management and the implementation of financial controls, safeguarding the company's assets and ensuring operational efficiency. This critical position supports the broader mission of enhancing human health and well-being by providing the financial framework for innovation and expansion in medical and digital healthcare sectors.

Chong Kim, the Chief Financial Officer & Chief Operating Officer at Dong-A Pharmaceutical, orchestrates both the financial health and the operational execution of the company's diverse business units. This dual role demands a comprehensive understanding of fiscal management and the seamless delivery of services across medical and digital healthcare, consumer products, logistics, IT services, and engineering. Chong Kim drives operational efficiency by streamlining processes, optimizing resource allocation, and ensuring the effective implementation of strategic initiatives. Simultaneously, the Chief Financial Officer & Chief Operating Officer manages financial planning, reporting, and investment strategies to support these extensive operations. By integrating financial discipline with operational excellence, Chong Kim ensures that Dong-A Pharmaceutical effectively delivers specialized medical services, health functional foods, and integrated logistics solutions. This leadership ensures the company meets its social responsibility goals and creates value for stakeholders through innovation and consumer-oriented management.

Won Kim, the President at Dong-A Pharmaceutical, provides overarching leadership and strategic direction for the entire organization. This executive guides the company's mission to enhance human health and well-being across all its operational sectors, including medical and digital healthcare, consumer products, logistics, IT services, and engineering. Won Kim champions innovation and fosters a culture of consumer-oriented management, ensuring that the company consistently creates value and leads change within the industry. The President's responsibilities include setting long-term objectives, overseeing major strategic decisions, and ensuring alignment across all departments to achieve the group's social responsibility goals. By directing the company's vision, Won Kim ensures the effective delivery of specialized medical services, health functional foods, and integrated logistics solutions. This leadership role is pivotal in maintaining Dong-A Pharmaceutical's commitment to advancing healthcare and improving quality of life through its diverse offerings.

Jung Kang, the Executive President at Dong-A Pharmaceutical, drives the execution of key strategic initiatives and operational enhancements across the company's diverse portfolio. This role focuses on translating the group's vision into actionable plans, ensuring that the company's commitment to social responsibility is realized through its medical and digital healthcare, consumer products, logistics, IT services, and engineering sectors. Jung Kang oversees the implementation of advanced healthcare solutions and the development of health functional foods, directly contributing to the enhancement of human health and well-being. The Executive President's focus on operational excellence supports the delivery of integrated logistics solutions and IT services, optimizing business processes for both internal functions and external clients. By championing innovation and consumer-centric approaches, Jung Kang ensures Dong-A Pharmaceutical maintains its leadership position and continues to create significant value within the healthcare industry and beyond.